Man-li Luo

107 Yanjiang West Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity in triple-negative breast cancer.

WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity in triple-negative breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 31, 2026

YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.

YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 13, 2026

An immunogenomic classification of solid tumours reveals subtype-specific therapeutic vulnerabilities for immunotherapy.

An immunogenomic classification of solid tumours reveals subtype-specific therapeutic vulnerabilities for immunotherapy.

Journal: EBioMedicine

Published: November 06, 2025

The arginine metabolism battlefield: how metabolite exchange in the tumor microenvironment shapes an immunosuppressive ecosystem.

The arginine metabolism battlefield: how metabolite exchange in the tumor microenvironment shapes an immunosuppressive ecosystem.

Journal: Cancer biology & medicine

Published: July 31, 2025

cGAS-STING activation mediated by FAM83H-AS1/HMGB1 elicits NF-κB-dependent immune evasion in breast cancer.

cGAS-STING activation mediated by FAM83H-AS1/HMGB1 elicits NF-κB-dependent immune evasion in breast cancer.

Journal: Science bulletin

Published: June 05, 2025

AKT1E17K-Interacting lncRNA SVIL-AS1 Promotes AKT1 Oncogenic Functions by Preferentially Blocking AKT1E17K Dephosphorylation.

AKT1E17K-Interacting lncRNA SVIL-AS1 Promotes AKT1 Oncogenic Functions by Preferentially Blocking AKT1E17K Dephosphorylation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 15, 2025

LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer.

LncRNA FAISL Inhibits Calpain 2-Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 04, 2024

ATR/Chk1 interacting lncRNA modulates DNA damage response to induce breast cancer chemoresistance.

ATR/Chk1 interacting lncRNA modulates DNA damage response to induce breast cancer chemoresistance.

Journal: Cell insight

Published: June 27, 2024

Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion.

Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion.

Journal: Cancer cell

Published: May 13, 2024

Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer.

Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer.

Journal: Cancers

Published: May 02, 2023

LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates.

LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates.

Journal: The EMBO journal

Published: August 21, 2022

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer.

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer.

Journal: Nature communications

Published: March 14, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026